Will AZ Legal Notice, Clotting Incidents Cloud Serum’s Fortunes?

Sputnik V New Challenger In India

 
• By Vibha Ravi

AstraZeneca has sent a legal notice to Indian partner Serum Institute for non-delivery of COVID-19 vaccines. Will this and the entry of a new challenger, Sputnik V, in the Indian market affect Serum’s fortunes? Will the EMA and MHRA announcement on clotting incidents related to the AZ vaccine shrink demand for the partnered vaccine?

Man on a seat lost at sea
Will Serum Successfully Ride The Storm? • Source: Shutterstock

More from COVID-19

More from Scrip